ABSTRACT
BACKGROUND: The success of cisplatin-based (Platinol, Bristol-Myers Squibb Company, New York, NY, USA) chemotherapy for testicular cancer comes at the price of long-term and late effects related to healthy tissue damage. We assessed and modelled serum platinum (Pt) decay after chemotherapy and determined relationships between long-term circulating Pt levels and known late effects. PATIENTS AND METHODS: In 99 testicular cancer survivors, treated with cisplatin-based chemotherapy, serum and 24-h urine samples were collected during follow-up (1-13 years after treatment). To build a population pharmacokinetic model, measured Pt data were simultaneously analysed, together with cisplatin dose, age, weight and height using the NONMEM software. Based on this model, area under the curve between 1 and 3 years after treatment (Pt AUC1-3 years) was calculated for each patient. Predicted long-term Pt exposure was related to renal function and to late effects of treatment assessed median 9 (3-15) years after chemotherapy. RESULTS: Decay of Pt was best described by a two-compartment model. Mean terminal T1/2 was 3.7 (range 2.5-5.2) years. Pt AUC1-3 years correlated with cumulative cisplatin dose, and creatinine clearance before and 1 year after treatment. Patients with paraesthesia had higher Pt AUC1-3 years (30.9 versus 27.0 µg/l month) compared with those without paraesthesia (P = 0.021). Patients with hypogonadism, elevated LDL-cholesterol levels or hypertension also had higher Pt AUC1-3 years. CONCLUSIONS: Renal function before and after cisplatin treatment is an important determinant of long-term Pt exposure. Known long-term effects of testicular cancer treatment, such as paraesthesia, hypogonadism, hypercholesterolaemia and hypertension, are associated with long-term circulating Pt exposure.
Subject(s)
Cisplatin/therapeutic use , Platinum/blood , Testicular Neoplasms/blood , Testicular Neoplasms/drug therapy , Adult , Cisplatin/adverse effects , Follow-Up Studies , Humans , Hypercholesterolemia/blood , Hypercholesterolemia/congenital , Hypercholesterolemia/diagnosis , Hypertension/blood , Hypertension/chemically induced , Hypertension/diagnosis , Male , Middle Aged , Testicular Neoplasms/diagnosis , Treatment Outcome , Young AdultABSTRACT
In this study, we investigated the effect of low density lipoprotein receptor (LDLr) deficiency on gap junctional connexin 36 (Cx36) islet content and on the functional and growth response of pancreatic beta-cells in C57BL/6 mice fed a high-fat (HF) diet. After 60 days on regular or HF diet, the metabolic state and morphometric islet parameters of wild-type (WT) and LDLr-/- mice were assessed. HF diet-fed WT animals became obese and hypercholesterolaemic as well as hyperglycaemic, hyperinsulinaemic, glucose intolerant and insulin resistant, characterizing them as prediabetic. Also they showed a significant decrease in beta-cell secretory response to glucose. Overall, LDLr-/- mice displayed greater susceptibility to HF diet as judged by their marked cholesterolaemia, intolerance to glucose and pronounced decrease in glucose-stimulated insulin secretion. HF diet induced similarly in WT and LDLr-/- mice, a significant decrease in Cx36 beta-cell content as revealed by immunoblotting. Prediabetic WT mice displayed marked increase in beta-cell mass mainly due to beta-cell hypertrophy/replication. Nevertheless, HF diet-fed LDLr-/- mice showed no significant changes in beta-cell mass, but lower islet-duct association (neogenesis) and higher beta-cell apoptosis index were seen as compared to controls. The higher metabolic susceptibility to HF diet of LDLr-/- mice may be explained by a deficiency in insulin secretory response to glucose associated with lack of compensatory beta-cell expansion.
Subject(s)
Cell Proliferation/drug effects , Diet, High-Fat , Dietary Fats/pharmacology , Insulin-Secreting Cells/pathology , Insulin-Secreting Cells/physiology , Receptors, LDL/deficiency , Animals , Apoptosis/drug effects , Connexins/metabolism , Diet, High-Fat/adverse effects , Disease Models, Animal , Female , Gap Junctions/metabolism , Glucose/metabolism , Glucose/pharmacology , Hypercholesterolemia/congenital , Hypercholesterolemia/etiology , Hypercholesterolemia/metabolism , Hypercholesterolemia/physiopathology , Insulin/metabolism , Insulin-Secreting Cells/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Prediabetic State/etiology , Prediabetic State/metabolism , Prediabetic State/physiopathology , Receptors, LDL/genetics , Receptors, LDL/metabolism , Gap Junction delta-2 ProteinABSTRACT
Vascular dysfunction has been associated with familial hypercholesterolaemia (FH), a severe form of hyperlipidaemia. We recently demonstrated that swine with FH exhibit reduced exercise-induced systemic, but not pulmonary, vasodilatation involving reduced nitric oxide (NO) bioavailability. Since NO normally limits endothelin (ET) action, we examined the hypothesis that reduced systemic vasodilatation during exercise in FH swine results from increased ET-mediated vasoconstriction. Systemic and pulmonary vascular responses to exercise were examined in chronically instrumented normal and FH swine in the absence and presence of the ETA/B receptor antagonist tezosentan. Intrinsic reactivity to ET was further assessed in skeletal muscle arterioles. FH swine exhibited â¼9-fold elevation in total plasma cholesterol versus normal swine. Similar to our recent findings, systemic, not pulmonary, vasodilatation during exercise was reduced in FH swine. Blockade of ET receptors caused marked systemic vasodilatation at rest and during exercise in normal swine that was significantly reduced in FH swine. The reduced role of ET in FH swine in vivo was not the result of decreased arteriolar ET responsiveness, as responsiveness was increased in isolated arterioles. Smooth muscle ET receptor protein content was unaltered by FH. However, circulating plasma ET levels were reduced in FH swine. ET receptor antagonism caused pulmonary vasodilatation at rest and during exercise in normal, but not FH, swine. Therefore, contrary to our hypothesis, FH swine exhibit a generalised reduction in the role of ET in regulating vascular tone in vivo probably resulting from reduced ET production. This may represent a unique vascular consequence of severe familial hypercholesterolaemia.
Subject(s)
Endothelins/blood , Hypercholesterolemia/metabolism , Lung/blood supply , Muscle, Skeletal/blood supply , Vasodilation , Animals , Arterioles/metabolism , Arterioles/physiology , Endothelin Receptor Antagonists/pharmacology , Hypercholesterolemia/congenital , Hypercholesterolemia/physiopathology , Physical Exertion , Pyridines/pharmacology , Receptors, Endothelin/genetics , Receptors, Endothelin/metabolism , Swine , Swine, Miniature , Tetrazoles/pharmacologyABSTRACT
BACKGROUND: Omega-6 fatty acids are important to fetal development. However, during gestation/lactation, these fatty acids may contribute toward the development of fat tissue. Omega-9 fatty acids are associated with a reduction in serum lipids and protection from liver disease. OBJECTIVES: The present study investigated the effect of the maternal intake of omega-6 and omega-9 in hypercholesterolemic mothers on the liver of the offspring. METHODS: LDL receptor-deficient mice were fed a diet rich in either omega-6 (E6D) or omega-9 (E9D) for 45 days prior to mating and until the birth of the offspring, evaluating the effect on the offspring liver in comparison to a standard diet (STD). RESULTS: Mothers fed with the E6D experienced an increase in total cholesterol (TC) and the offspring exhibited an increase in TC, hepatic triglycerides (TG), and CC-chemokine ligand (CCL)2/monocyte chemoattractant protein (MCP)-1 as well as a reduction in HDL. Histological analysis on this group revealed steatosis, leukocyte infiltrate, and increased CCL2/MCP-1 expression. The ultrastructural analysis revealed hepatocytes with lipid droplets and myofibroblasts. The offspring of mothers fed the standard diet exhibited low serum TC, but microvesicular steatosis was observed. The offspring of mothers fed the E9D exhibited lower serum and hepatic TG as well as higher LDL in comparison to the other diets. The histological analyses revealed lower steatosis and leukocyte infiltrate. CONCLUSIONS: The findings suggest that hypercholesterolemic mothers with a diet rich in omega-6 fatty acids predispose their offspring to steatohepatitis, whereas a diet rich in omega-9 has a protective effect.
Subject(s)
Embryo, Mammalian/drug effects , Fatty Acids, Monounsaturated/administration & dosage , Fatty Acids, Omega-6/administration & dosage , Liver/drug effects , Maternal Exposure/adverse effects , Receptors, LDL/metabolism , Animal Feed , Animals , Animals, Newborn , Embryo, Mammalian/embryology , Embryonic Development/drug effects , Fatty Liver/chemically induced , Fatty Liver/pathology , Female , Fetal Development/drug effects , Hepatocytes/drug effects , Hepatocytes/ultrastructure , Hypercholesterolemia/chemically induced , Hypercholesterolemia/congenital , Hypercholesterolemia/metabolism , Liver/embryology , Liver/growth & development , Mice , Mice, Inbred C57BL , Mice, Knockout , Pregnancy , Receptors, LDL/deficiencyABSTRACT
The DNA content, thymidine incorporation into DNA, and free and esterified cholesterol contents of cultured aortic smooth muscle cells (SMCs) of normal and WHHL rabbits were compared. In the first series of experiments, 5 groups of cultured normal rabbit aortic SMCs were compared: control cells and cells treated with LDL from normolipemic rabbit plasma (LDLN) and (DL from hypercholesterolemic rabbit plasma (LDLW), LDLN plus esterastin and LDLW plus esterastin. In the second series, the same groups of hereditable hypercholesterolemic WHHL rabbit aortic SMCs were compared. Results obtained with normal aortic SMCs showed that internalization of LDLW was higher than that of LDLN. LDLW was also more effective than LDLN for elevating thymidine incorporation into DNA. LDLW plus esterastin caused increases of 5, 7 and 3 times the control values in thymidine incorporation, and esterified and free cholesterol contents of the cells, respectively. In the control groups, thymidine incorporation into DNA of WHHL SMCs was 12 times more than that into the normal cells, and the free cholesterol content of WHHL cells was twice that of normal cells. Addition of LDLN caused further increases in thymidine incorporation and the esterified and free cholesterol contents of the cells. Esterastin had only a slight effect on these extremely high values. LDLW itself had no effect except that when added with esterastin it increased the cholesterol ester content of WHHL cells. The results are discussed with respect to metabolic differences between cultured aortic SMCs of normal and WHHL rabbits, and LDLs prepared from normal and hypercholesterolemic (WHHL) rabbit plasma.